KONINKLIJKE PHILIPS NV ADR

NYSE: PHG (Koninklijke Philips N.V. NY Reg)

Last update: 22 Dec, 2024, 3:33PM

25.11

0.08 (0.32%)

Previous Close 25.03
Open 24.90
Volume 563,137
Avg. Volume (3M) 771,728
Market Cap 23,399,657,472
Price / Earnings (Forward) 12.72
Price / Sales 1.29
Price / Book 1.86
52 Weeks Range
19.55 (-22%) — 32.91 (31%)
Earnings Date 11 Feb 2025
Profit Margin -1.82%
Operating Margin (TTM) 7.72%
Diluted EPS (TTM) -0.510
Quarterly Revenue Growth (YOY) -2.10%
Quarterly Earnings Growth (YOY) 105.70%
Total Debt/Equity (MRQ) 69.35%
Current Ratio (MRQ) 1.16
Operating Cash Flow (TTM) 1.80 B
Levered Free Cash Flow (TTM) 1.85 B
Return on Assets (TTM) 1.36%
Return on Equity (TTM) -4.59%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock Koninklijke Philips N.V. NY Reg - -

AIStockmoo Score

-0.2
Analyst Consensus NA
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 3.5
Technical Oscillators -2.0
Average -0.17

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
PHG 23 B - - 1.86
BSX 143 B - 79.93 6.75
SYK 139 B 0.89% 39.08 6.83
ABT 204 B 1.93% 35.47 5.04
MDT 102 B 3.49% 24.43 2.25
GMED 11 B - 135.39 2.91

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.

Sector Healthcare
Industry Medical Devices
Investment Style Large Core
% Held by Institutions 6.87%

Ownership

Name Date Shares Held
Exor N.V. 30 Sep 2024 164,553,857

No data within this time range.

No data within this time range.

Date Type Details
09 Jan 2025 Announcement Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region
09 Jan 2025 Announcement Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region
09 Dec 2024 Announcement NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App
03 Dec 2024 Announcement Philips aims to advance cardiac MRI technology through AI-driven research
03 Dec 2024 Announcement Philips aims to advance cardiac MRI technology through AI-driven research
01 Dec 2024 Announcement Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024
01 Dec 2024 Announcement Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024
01 Dec 2024 Announcement Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24
01 Dec 2024 Announcement Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24
26 Nov 2024 Announcement Philips and AWS expand strategic collaboration to advance HealthSuite cloud services and power generative AI workflows
26 Nov 2024 Announcement Philips and AWS expand strategic collaboration to advance HealthSuite cloud services and power generative AI workflows
25 Nov 2024 Announcement Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24
25 Nov 2024 Announcement Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24
22 Nov 2024 Announcement Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities
21 Nov 2024 Announcement Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24
21 Nov 2024 Announcement Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24
13 Nov 2024 Announcement Philips Norelco and actor Adam Scott pay tribute to "The King of Beards" this holiday
12 Nov 2024 Announcement Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance
04 Nov 2024 Announcement Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
04 Nov 2024 Announcement Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
30 Oct 2024 Announcement Philips and Aspen Dental launch multi-year Sonicare-brand partnership
29 Oct 2024 Announcement Philips to Further Roll Out RATE: AI for Early Infection Detection at U.S. Department of Defense Through Four-Year, $25 Million Contract
28 Oct 2024 Announcement Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world
28 Oct 2024 Announcement Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world
24 Oct 2024 Announcement Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments
24 Oct 2024 Announcement Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments
21 Oct 2024 Announcement Philips showcases next level cardiology innovations for improved patient care at TCT 2024
Show more
5Y Average Dividend Yield 1.78%
Ex Date Announcement Date Payment Date Details
12 May 2022 07 Jun 2022 08 Jun 2022 0.912092 Cash
10 May 2021 25 Jan 2021 09 Jun 2021 1.034025 Cash
13 May 2019 19 Apr 2019 13 Jun 2019 0.961222 Cash
07 May 2018 31 Jan 2018 06 Jun 2018 0.9394 Cash
12 May 2017 - 14 Jun 2017 0.762926 Cash
13 May 2016 - 15 Jun 2016 0.766224 Cash
08 May 2015 - 10 Jun 2015 0.759016 Cash
05 May 2014 - 04 Jun 2014 0.925548 Cash
07 May 2013 - 05 Jun 2013 0.82926 Cash
02 May 2012 - 31 May 2012 0.801082 Cash
04 Apr 2011 - 04 May 2011 0.945859 Cash
29 Mar 2010 - 28 Apr 2010 0.792599 Cash
30 Mar 2009 - 07 Apr 2009 0.796824 Cash
28 Mar 2008 - 07 Apr 2008 1.09424 Cash
30 Mar 2007 - 10 Apr 2007 0.80112 Cash
31 Mar 2006 - 10 Apr 2006 0.53953 Cash
01 Apr 2005 - 11 Apr 2005 0.5144 Cash
26 Mar 2004 - 05 Apr 2004 0.44006 Cash
28 Mar 2003 - 07 Apr 2003 0.38988 Cash
02 Apr 2002 - 08 Apr 2002 0.31709 Cash
30 Mar 2001 - 18 Apr 2001 0.31975 Cash
27 Jul 2000 - 04 Aug 2000 1.168776 Cash
05 Apr 2000 - 19 Apr 2000 1.14288 Cash
26 May 1999 - 03 Jun 1999 4.289884 Cash
26 Mar 1999 - 14 Apr 1999 1.08717 Cash
17 Mar 1998 - 03 Apr 1998 0.9712 Cash
24 Mar 1997 - 11 Apr 1997 0.84818 Cash
26 Mar 1996 - 16 Apr 1996 0.82155 Cash
03 May 1995 - 31 May 1995 0.68192 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2022 0.912 1 6.09
2021 1.03 1 2.81
2019 0.961 1 1.97
2018 0.939 1 2.68
2017 0.763 1 2.02
2016 0.766 1 2.51
2015 0.759 1 2.98
2014 0.926 1 3.19
2013 0.829 1 2.24
2012 0.801 1 3.02
2011 0.946 1 4.52
2010 0.793 1 2.58
2009 0.797 1 2.71
2008 1.09 1 5.51
2007 0.801 1 1.87
2006 0.540 1 1.44
2005 0.514 1 1.65
2004 0.440 1 1.66
2003 0.390 1 1.34
2002 0.317 1 1.79
2001 0.320 1 1.10
2000 2.31 2 6.38
1999 5.38 2 15.93
1998 0.971 1 5.74
1997 0.848 1 5.61
1996 0.822 1 8.22
1995 0.682 1 7.60
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria